CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-15 | LEWIS JOEL President and CEO | Grant or award | +13,196 | $1.46 | $19K | 897,362 |
| 2023-05-31 | LEWIS JOEL President and CEO | Grant or award | +12,272 | $1.57 | $19K | 884,166 |
| 2023-05-15 | LEWIS JOEL President and CEO | Grant or award | +11,748 | $1.64 | $19K | 871,894 |
| 2023-04-28 | LEWIS JOEL President and CEO | Grant or award | +10,947 | $1.76 | $19K | 860,146 |
| 2023-04-14 | LEWIS JOEL President and CEO | Grant or award | +9,585 | $2.01 | $19K | 849,199 |
| 2023-03-31 | LEWIS JOEL President and CEO | Grant or award | +9,175 | $2.10 | $19K | 839,614 |
| 2023-03-15 | LEWIS JOEL President and CEO | Grant or award | +10,140 | $1.90 | $19K | 830,439 |
| 2023-03-01 | LEWIS JOEL President and CEO | Shares withheld for taxes | −75,529 | $2.07 | $156K | 820,299 |
| 2023-02-28 | LEWIS JOEL President and CEO | Grant or award | +9,308 | $2.07 | $19K | 895,828 |
| 2023-02-21 | ELDRED KARY Director | Purchase | +1,000 | $1.59 | $2K | 47,215 |
| 2023-02-16 | LEWIS JOEL President and CEO | Purchase | +1,000 | $1.52 | $2K | 1,000 |
| 2023-02-15 | LEWIS JOEL President and CEO | Grant or award | +13,380 | $1.44 | $19K | 886,520 |
| 2023-02-07 | LEWIS JOEL President and CEO | Grant or award | +143,836 | $1.43 | $206K | 873,140 |
| 2023-01-31 | LEWIS JOEL President and CEO | Grant or award | +15,086 | $1.16 | $17K | 729,304 |
| 2023-01-26 | Zordani Richard A. Jr. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-01-26 | Shlevin Harold H. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-01-26 | Schwartz Elissa J. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-01-26 | Rubin Marc Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-01-26 | OMENN GILBERT S Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2023-01-26 | FREEMAN KEVIN D Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 |
Page 17 of 21 · 404 trades